Roles of phosphatidylinositol 3-kinase-Akt and NADPH oxidase in adenosine 5'-triphosphate-sensitive K+ channel function impaired by high glucose in the human artery

Hypertension. 2008 Sep;52(3):507-13. doi: 10.1161/HYPERTENSIONAHA.108.118216. Epub 2008 Aug 4.

Abstract

The present study was designed to examine roles of the phosphatidylinositol 3-kinase-Akt pathway and reduced nicotinamide-adenine dinucleotide phosphate oxidases in the reduced ATP-sensitive K(+) channel function via superoxide produced by high glucose in the human artery. We evaluated the activity of the phosphatidylinositol 3-kinase-Akt pathway, as well as reduced nicotinamide-adenine dinucleotide phosphate oxidases, the intracellular levels of superoxide and ATP-sensitive K(+) channel function in the human omental artery without endothelium. Levels of the p85-alpha subunit and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits, including p47phox, p22phox, and Rac-1, increased in the membrane fraction from arteries treated with D-glucose (20 mmol/L) accompanied by increased intracellular superoxide production. High glucose simultaneously augmented Akt phosphorylation at Ser 473, as well as Thr 308 in the human vascular smooth muscle cells. A phosphatidylinositol 3-kinase inhibitor LY294002, as well as tiron and apocynin, restored vasorelaxation and hyperpolarization in response to an ATP-sensitive K(+) channel opener levcromakalim. Therefore, it can be concluded that the activation of the phosphatidylinositol 3-kinase-Akt pathway, in combination with the translocation of p47phox, p22phox, and Rac-1, contributes to the superoxide production induced by high glucose, resulting in the impairment of ATP-sensitive K(+) channel function in the human visceral artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Arteries / cytology
  • Arteries / drug effects
  • Arteries / enzymology*
  • Chromones / pharmacology
  • Cromakalim / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Glucose / pharmacology
  • Glyburide / pharmacology
  • Humans
  • Hyperglycemia / drug therapy
  • Hyperglycemia / metabolism*
  • Hypoglycemic Agents / pharmacology
  • In Vitro Techniques
  • KATP Channels / metabolism*
  • Morpholines / pharmacology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology
  • NADPH Oxidases / metabolism*
  • Omentum / blood supply
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Superoxides / metabolism
  • rac1 GTP-Binding Protein / metabolism

Substances

  • Antihypertensive Agents
  • Chromones
  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • KATP Channels
  • Morpholines
  • RAC1 protein, human
  • Cromakalim
  • Superoxides
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • NADPH Oxidases
  • CYBA protein, human
  • neutrophil cytosolic factor 1
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • rac1 GTP-Binding Protein
  • Glucose
  • Glyburide